Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Type 2 Diabetes
NCT01508923Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- May 2001
- Primary completion
- Feb 2002
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started May 2001; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01508923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01508923.